Originally established in 1993 and acquired by Thermo Fisher Scientific in 2017, Patheon is today one of the best recognised global CDMOs, supporting pharmaceutical companies in bringing high‑quality medicines to patients worldwide. Thermo Fisher’s mission, “to enable our customers to make the world healthier, cleaner and safer”, lies at the core of Patheon’s operations and strategic vision.
With manufacturing sites across Canada, the United States, Puerto Rico, Europe, Japan and Australia, Patheon offers end‑to‑end solutions that include formulation development, clinical supply, commercial manufacturing, packaging and logistics.




















